Efficacy and safety of Shu-gan-qing-re formula for generalized anxiety disorder: study protocol for a multi-center, prospective, double-blind, double-dummy, randomized controlled trial
DiscussionThe study will provide scientific and objective assessments for the efficacy and safety of SGQR formula for patients with GAD, hopefully offering clinicians an alternative approach to GAD.Trial registrationChinese Clinical Trial Registry, ID:ChiCTR-IPR-17013058. Registered on October 20, 2017.
Source: Trials - Category: Research Source Type: clinical trials
More News: Anxiety | Buspirone | China Health | Clinical Trials | Depression | Generalized Anxiety Disorder (GAD) | Hospitals | Men | Psychology | Research | Study